동성제약

002210KOSPI의약품 제조업

40.0 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure6.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Dongseong Pharmaceutical operates 13 facilities across South Korea, with headquarters in Seoul, and is divided into three business segments: pharmaceuticals, hair dyes, and cosmetics. Key products include Jeongrohwan, Seven Eight, and Lances, with pharmaceuticals and hair dyes produced in-house at the Asan plant, while cosmetics are sold through purchased goods.

Number of Employees

307people

Average Salary

42.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 16.864.0Point

PBR

0.47Industry Average 1.137.0Point

Half of industry avg (excellent)

ROE

-15.27Industry Average 2.940.0Point

Well below industry avg

Debt Ratio

175.31Industry Average 53.870.0Point

3.3x industry avg (risky)

Trend 2022~20240.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼2.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼543.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.1% (declining, 2yr)

Detailed News Sentiment

5 totalPositive 1Neutral 0Negative 1Average Sentiment Score 50

Negative
동성제약, 0.94% 소규모 감자…특정 주주 지분 정리
동성제약은 회생계획에 따른 자본구조 조정을 위해 특정 주주 이모씨가 보유한 주식 25만주를 무상 소각하는 소규모 감자를 결정했습니다.
Positive
동성제약 회생계획 인가…법원 “모든 이해관계인의 이익에 부합”
동성제약은 서울회생법원으로부터 채권자 보호와 기업 존속의 공익적 가치를 고려한 회생계획 인가 결정을 받았습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 973Won52-week high 2,17252-week low 973

1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

32 totalPositive 4Neutral 24Negative 4

Neutral주식등의대량보유상황보고서(약식)2026-04-10
Neutral[기재정정]주요사항보고서(감자결정)2026-04-09
Positive[기재정정]주요사항보고서(유상증자결정)2026-04-09
Positive유상증자또는주식관련사채등의발행결과(자율공시)2026-04-09
Neutral기타경영사항(자율공시)2026-04-08